ReviewCureus2026
Risk Factors for 30-Day Hospital Readmission in Patients With Cancer: A Systematic Review With Emphasis on Older Adults.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thirty-day hospital readmission is a key indicator of healthcare quality, particularly in patients with cancer who are at an increased risk due to multimorbidity, treatment-related complications, and functional decline. Although older adults represent a vulnerable subgroup, evidence specific to geriatric oncology remains limited. This systematic review aimed to identify and synthesise risk factors for 30-day hospital readmission among patients with cancer, with particular emphasis on older adults. A systematic search of MEDLINE, Embase, and the Cochrane Library (January 2015 to March 2026) was conducted in accordance with PRISMA 2020 guidelines. Eight observational studies were included. Risk factors were categorised into clinical, functional, treatment-related, and social domains. Clinical factors, including comorbidity burden and abnormal laboratory parameters (particularly hypoalbuminaemia), were the most consistently reported predictors. Functional impairment and geriatric-specific factors were strongly associated with the risk of readmission in studies focusing on older adults. Treatment-related factors such as prolonged length of stay and polypharmacy, along with social determinants including limited social support, further contributed to increased risk. Considerable heterogeneity across study populations, methodologies, and outcome reporting precluded meta-analysis. Overall, the evidence suggests that readmission risk in patients with cancer is multifactorial, with consistent direction of association across studies despite variability in magnitude. However, the limited number of geriatric-specific studies highlights a critical gap in the literature. These findings support the need for multidimensional risk assessment and targeted transitional care interventions. Future research should prioritise prospective, geriatric-focused studies and the development of validated risk prediction models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.